Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
19 hedge funds and large institutions have $825K invested in Biocept, Inc. in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, reducing their positions, and 4 closing their positions.
181% more capital invested
Capital invested by funds: $294K → $825K (+$531K)
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
27% more funds holding
Funds holding: 15 → 19 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$466K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
| 3 |
Barclays
London,
United Kingdom
|
+$80.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$11K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11K |
| 3 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$7K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6K |
BIOC Hedge Fund Activity: Q1 2020 in Review
19 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2020, worth a combined $825K — up 181% from $294K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BIOC positions and 4 closed out — a net gain of 4 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $466K. The largest seller was Anson Funds Management, exiting entirely with an estimated $11K sold.
- 19 institutional investors held Biocept, Inc. (BIOC) as of Q1 2020, up from 15 in Q4 2019.
- Funds reported $825K of Biocept, Inc. stock for Q1 2020, up 181% quarter-over-quarter.
- 8 funds opened new Biocept, Inc. positions in Q1 2020 and 4 closed out, a net change of +4 holders.
- The largest Biocept, Inc. buyer in Q1 2020 was Renaissance Technologies, an estimated $466K added.
- The largest Biocept, Inc. seller in Q1 2020 was Anson Funds Management, an estimated $11K sold.
Based on aggregated 13F filings for Q1 2020.